Imaging of bone marrow involvement in lymphoma: State of the art and future directions

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 391-402

  Kwee, Thomas C ^a   De Klerk, John M H ^b   Nievelstein, Rutger A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow; CT; Imaging; Lymphoma; MRI; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE MARROW; BONE MARROW BIOPSY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SAMPLING ERROR;

BONE MARROW; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 79952372439     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.40     Document Type: Review

References (60)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M.J. (2009) Cancer statistics, 2009. CA Cancer J. Clin.59, 225-249.
2. Armitage, J.O. (2005) Staging non-Hodgkin lymphoma. CA Cancer J. Clin.55, 368-376
3. Connors, J.M. (2005) State-of-the-art therapeutics: Hodgkin's lymphoma. J. Clin. Oncol.23, 6400-6408.
4. Bain, B.J. (2006) Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica91, 1293-1294.
5. Bairey, O. and Shpilberg, O. (2007) Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma? ActaHaematol.118, 61-64. (Pubitemid 47014343)
6. Brunning, R.D., Bloomfield, C.D., McKenna, R.W., and Peterson, L.A. (1975) Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann. Intern. Med.82, 365-366.
7. Coller, B.S., Chabner, B.A., and Gralnick, H.R. (1977) Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am. J. Hematol.3, 105-119. (Pubitemid 8261709)
8. Haddy, T.B., Parker, R.I., and Magrath, I.T. (1989) Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. Med. Pediatr. Oncol.17, 418-423. (Pubitemid 19248194)
9. Wang, J., Weiss, L.M., Chang, K.L., Slovak, M.L., Gaal, K., Forman, S.J., and Arber, D.A. (2002) Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer94, 1522-1531. (Pubitemid 34212647)
10. Vassilakopoulos, T.P., Angelopoulou, M.K., Constantinou, N., Karmiris, T., Repoussis, P., Roussou, P., Siakantaris, M.P., Korkolopoulou, P., Kyrtsonis, M.C., Kokoris, S.I., Dimopoulou, M.N., Variamis, E., Viniou, N.A., Konstantopoulos, K., Dimitriadou, E.M., Androulaki, A., Patsouris, E., Doussis-Anagnostopoulou, I.A., Panayiotidis, P., Boussiotis, V.A., Kittas, C., and Pangalis, G.A. (2005) Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood105, 1875-1880. (Pubitemid 40731767)
11. Vanel, D., Husband, J.E., and Padhani, A.R. (1998) Bone metastases. In Imaging in Oncology. 2nd ed. Husband, J.E. and Reznek, R.E., Eds. Taylor & Francis, London. pp. 1041-1058.
12. Kricun, M.E. (1985) Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol.14, 10-19.
13. Edelstyn, G.A., Gillespie, P.J., and Grebbell, F.S. (1967) The radiological demonstration of osseous metastases. Experimental observations. Clin. Radiol.18, 158-162.
14. Kröpil, P., Fenk, R., Fritz, L.B., Blondin, D., Kobbe, G., Mödder, U., and Cohnen, M. (2008) Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur. Radiol.18, 51-58. (Pubitemid 351217276)
15. Mahnken, A.H., Wildberger, J.E., Gehbauer, G., Schmitz-Rode, T., Blaum, M., Fabry, U., and Günther, R.W. (2002) Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am. J. Roentgenol. 178, 1429-1436. (Pubitemid 34547826)
16. Vinnicombe, S.J. and Reznek, R.H. (2003) Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur. J. Nucl. Med. Mol. Imaging30 (Suppl1), S42-55.
17. Liu, F.Y., Chang, J.T., Wang, H.M., Liao, C.T., Kang, C.J., Ng, S.H., Chan, S.C., and Yen, T.C. (2006) [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J. Clin. Oncol. 24, 599-604. (Pubitemid 46630422)
18. Basu, S. and Alavi, A. (2007) Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting. J. Clin. Oncol.25, 1297. (Pubitemid 46640588)
19. Rohren, E.M., Turkington, T.G., and Coleman, R.E. (2004) Clinical applications of PET in oncology. Radiology231, 305-332. (Pubitemid 38552885)
20. Weiler-Sagie, M., Bushelev, O., Epelbaum, R., Dann, E.J., Haim, N., Avivi, I., Ben-Barak, A., Ben-Arie, Y., Bar-Shalom, R., and Israel, O. (2010) (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J. Nucl. Med.51, 25-30.
21. Paul, R. (1987) Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J. Nucl. Med.28, 288-292.
22. Kwee, T.C., Kwee, R.M., and Nievelstein, R.A. (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood111, 504-516.
23. Mawlawi, O. and Townsend, D.W. (2009) Multimodality imaging: an update on PET/CT technology. Eur. J. Nucl. Med. Mol. Imaging36 (Suppl 1), S15-29.
24. Moog, F., Bangerter, M., Kotzerke, J., Guhlmann, A., Frickhofen, N., and Reske, S.N. (1998) 18-Ffluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J. Clin. Oncol.16, 603-609. (Pubitemid 28135606)
25. Pakos, E.E., Fotopoulos, A.D., and Ioannidis, J.P. (2005) 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J. Nucl. Med. 46, 958-963. (Pubitemid 43733510)
26. Schaefer, N.G., Strobel, K., Taverna, C., and Hany, T.F. (2007) Bone involvement in patients with lymphoma: the role of FDG-PET/CT.Eur. J. Nucl. Med. Mol. Imaging34, 60-67. (Pubitemid 44885555)
27. Pelosi, E., Penna, D., Deandreis, D., Chiappella, A., Skanjeti, A., Vitolo, U., and Bisi, G. (2008) FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Q. J. Nucl. Med. Mol. Imaging52, 9-16. (Pubitemid 351351040)
28. Ngeow, J.Y., Quek, R.H., Ng, D.C., Hee, S.W., Tao, M., Lim, L.C., Tan, Y.H., and Lim, S.T. (2009) High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann. Oncol.20, 1543-1547.
29. Moulin-Romsee, G., Hindié, E., Cuenca, X., Brice, P., Decaudin, D., Bénamor, M., Brière, J., Anitei, M., Filmont, J.E., Sibon, D., de Kerviler, E., and Moretti J.L. (2010) (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur. J. Nucl. Med. Mol. Imaging37, 1095-1105.
30. Kadrmas, D.J., Casey, M.E., Conti, M., Jakoby, B.W., Lois, C., and Townsend, D.W. (2009) Impact of time-of-flight on PET tumor detection. J. Nucl. Med.50, 1315-1323.
31. Hustinx, R., Smith, R.J., Benard, F., Rosenthal, D.I., Machtay, M., Farber, L.A., and Alavi, A. (1999) Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur. J. Nucl. Med. 26, 1345-1348. (Pubitemid 29467031)
32. Basu, S., Kung, J., Houseni, M., Zhuang, H., Tidmarsh, G.F., and Alavi, A. (2009) Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. Q. J. Nucl. Med. Mol. Imaging53, 9-19.
33. Sanz-Viedma, S., Torigian, D.A., Parsons, M., Basu, S., and Alavi, A. (2009) Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging. Rev. Esp. Med. Nucl.28, 159-166.
34. Ahmadzadehfar, H., Sabet, A., Näke, K., Hinterthaner, B., Biersack, H.J., and Ezziddin, S. (2009) Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer. Clin. Nucl. Med.34, 168-170.
35. Vogler, J.B., 3rd and Murphy, W.A. (1988) Bone marrow imaging.Radiology168, 679-693.
36. Vande Berg, B.C., Malghem, J., Lecouvet, F.E., and Maldague, B. (1998) Magnetic resonance imaging of normal bone marrow. Eur. Radiol. 8, 1327-1334.
37. Kuo, R., Panchal, M., Tanenbaum, L., and Crues, J.V., 3rd. (2007) 3.0 Tesla imaging of the musculoskeletal system. J. Magn. Reson. Imaging25, 245-261. (Pubitemid 46204575)
38. Mirowitz, S.A., Apicella, P., Reinus, W.R., and Hammerman, A.M. (1994) MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR Am. J. Roentgenol.162, 215-221. (Pubitemid 24043704)
39. Yasumoto, M., Nonomura, Y., Yoshimura, R., Haraguchi, K., Ito, S., Ohashi, I., and Shibuya, H. (2002) MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging. Skeletal Radiol.31, 263-269. (Pubitemid 36075468)
40. Tokuda, O., Hayashi, N., and Matsunaga, N. (2004) MRI of bone tumors: fast STIR imaging as a substitute for T1-weighted contrast-enhanced fat-suppressed spin-echo imaging. J. Magn. Reson. Imaging 19, 475-481. (Pubitemid 38437156)
41. Mahnken, A.H., Wildberger, J.E., Adam, G., Stanzel, S., Schmitz-Rode, T., Günther, R.W., and Buecker, A. (2005)Is there a need for contrast-enhanced T1-weighted MRI of the spine after inconspicuous short tau inversion recovery imaging? Eur. Radiol.15, 1387-1392. (Pubitemid 40983521)
42. Nakanishi, K., Kobayashi, M., Nakaguchi, K., Kyakuno, M., Hashimoto, N., Onishi, H., Maeda, N., Nakata, S., Kuwabara, M., Murakami, T., and Nakamura, H. (2007) Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn. Reson. Med. Sci.6, 147-155.
43. Takenaka, D., Ohno, Y., Matsumoto, K., Aoyama, N., Onishi, Y., Koyama, H., Nogami, M., Yoshikawa, T., Matsumoto, S., and Sugimura, K. (2009) Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J. Magn. Reson. Imaging30, 298-308.
44. Kwee, T.C., Fijnheer, R., Ludwig, I., Quarles van Ufford, H.M., Uiterwaal, C.S., Bierings, M.B., Takahara, T., and Nievelstein, R.A. (2010) Whole-body magnetic resonance imaging, including diffusion-weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma. Br. J. Haematol.149, 628-630.
45. Hanna, S.L., Fletcher, B.D., Fairclough, D.L., Jenkins, J.H., 3rd, and Le, A.H. (1991) Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy. Skeletal Radiol.20, 79-84.
46. Linden, A., Zankovich, R., Theissen, P., Diehl V., and Schicha H. (1989) Malignant lymphoma: bone marrow imaging versus biopsy. Radiology173, 335-339. (Pubitemid 19264580)
47. Kwee, T.C., Kwee, R.M., Verdonck, L.F., Bierings, M.B., and Nievelstein, R.A. (2008) Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma. Br. J. Haematol.141, 60-68. (Pubitemid 351350610)
48. Kwee, T.C., van Ufford, H.M., Beek, F.J., Takahara, T., Uiterwaal, C.S., Bierings, M.B., Ludwig, I., Fijnheer, R., and Nievelstein, R.A. (2009) Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest. Radiol.44, 683-690.
49. Punwani, S., Taylor, S.A., Bainbridge, A., Prakash, V., Bandula, S., De Vita, E., Olsen, O.E., Hain, S.F., Stevens, N., Daw, S., Shankar, A., Bomanji, J.B., and Humphries, P.D. (2010) Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology255, 182-190.
50. Brennan, D.D., Gleeson, T., Coate, L.E., Cronin, C., Carney, D., and Eustace, S.J. (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. AJR Am. J. Roentgenol.185, 711-716.
51. Ribrag, V., Vanel, D., Leboulleux, S., Lumbroso, J., Couanet, D., Bonniaud, G., Aupérin, A., Masson, F., Bosq, J., Edeline, V., Fermé, C., Pigneur, F., and Schlumberger. M. (2008) Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur. J. Radiol.66, 325-331. (Pubitemid 351626403)
52. Tsunoda, S., Takagi, S., Tanaka, O., and Miura, Y. (1997) Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma. Blood89, 286-290. (Pubitemid 26428204)
53. Senéterre, E., Weissleder, R., Jaramillo, D., Reimer, P., Lee, A.S., Brady, T.J., and Wittenberg, J. (1991) Bone marrow: ultrasmallsuperparamagnetic iron oxide for MR imaging. Radiology179, 529-533.
54. Vande Berg, B.C., Lecouvet, F.E., Kanku, J.P., Jamart, J., Van Beers, B.E., Maldague, B., and Malghem, J. (1999) Ferumoxides-enhanced quantitative magnetic resonance imaging of the normal and abnormal bone marrow: preliminary assessment. J. Magn. Reson. Imaging9, 322-328.
55. Daldrup-Link, H.E., Rummeny, E.J., Ihssen, B., Kienast, J., and Link, T.M. (2002) Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur. Radiol.12, 1557-1566. (Pubitemid 36940237)
56. Metz, S., Lohr, S., Settles, M., Beer, A., Woertler, K., Rummeny, E.J., and Daldrup-Link, H.E. (2006) Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas. Eur. Radiol.16, 598-607. (Pubitemid 44149372)
57. Von Schulthess, G.K. and Schlemmer, H.P. (2009) A look ahead: PET/MR versus PET/CT. Eur. J. Nucl. Med. Mol. Imaging36 (Suppl 1), S3-9.
58. Johnson, T.R., Krauss, B., Sedlmair, M., Grasruck, M., Bruder, H., Morhard, D., Fink, C., Weckbach, S., Lenhard, M., Schmidt, B., Flohr, T., Reiser, M.F., and Becker, C.R. (2007) Material differentiation by dual energy CT: initial experience. Eur. Radiol.17, 1510-1517. (Pubitemid 46767599)
59. Graser, A., Johnson, T.R., Chandarana, H., and Macari, M. (2009) Dual energy CT: preliminary observations and potential clinical applications in the abdomen. Eur. Radiol.19, 13-23.
60. Pache, G., Krauss, B., Strohm, P., Saueressig, U., Blanke, P., Bulla, S., Schäfer, O., Helwig, P., Kotter, E., Langer, M., and Baumann, T. (2010) Dual-energy CT virtual noncalcium technique: detecting posttraumatic bone marrow lesions - feasibility study. Radiology256, 617-624.